Living donor liver transplantation in small-for-size setting

Small-for-Size Syndrome (SFSS) is one of the most feared complication of adult split liver and living donor liver transplantation. SFSS stems from a disproportionate/excessive portal vein flow relative to the volume of the implanted liver graft, and is currently one of the major practical limits to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of surgery (London, England) England), 2020-10, Vol.82, p.134-137
Hauptverfasser: Ikegami, Toru, Balci, Deniz, Jung, Dong-Hwan, Kim, Jong Man, Quintini, Cristiano
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Small-for-Size Syndrome (SFSS) is one of the most feared complication of adult split liver and living donor liver transplantation. SFSS stems from a disproportionate/excessive portal vein flow relative to the volume of the implanted liver graft, and is currently one of the major practical limits to partial liver grafts’ transplantation. In the last few decades many graft inflow modulation (GIM) techniques have been proposed to curtail the portal vein flow, allowing for successful transplantation of small partial liver grafts. Graft inflow modulation techniques span from Splenic Artery Ligation (SAL), to Splenectomy, Porto-Systemic Shunts and the lately proposed Splenic Devascularization. A patient tailored approach balancing the risk of SFSS with GIM specific morbidity, is more important than identifying the ideal GIM technique. Here we summarize the most recently published data to provide general indications in the challenging preoperative choice of a GIM techniques. •Graft Inflow Modulation (GIM) is critical for the success of Living Donor Liver Transplantation using small grafts.•Each GIM technique produces different portal flow modulation and is characterized by different morbidity.•Decision making algorithms should take into consideration patient's conditions, portal hypertension, graft size and donor age.
ISSN:1743-9191
1743-9159
DOI:10.1016/j.ijsu.2020.07.003